HONG KONG (Reuters) - Fighting the deadly H5N1 bird flu virus is all the more difficult because experts are still figuring out how best to use Tamiflu, believed to be one of the very few defences, scientists said.
Roche AG's Tamiflu, generically called oseltamivir, is an anti-viral designed to fight human influenza. But tests have suggested it may be effective in reducing the severity of H5N1 and its complications if taken in higher doses.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!